Loading...
XHEL
TTALO
Market cap1.62bUSD
Apr 11, Last price  
11.24EUR
1D
0.54%
1Q
3.88%
IPO
10.63%
Name

Terveystalo Oyj

Chart & Performance

D1W1MN
P/E
19.85
P/S
1.06
EPS
0.57
Div Yield, %
2.67%
Shrs. gr., 5y
-0.11%
Rev. gr., 5y
5.39%
Revenues
1.34b
+4.17%
474,125,000505,619,000546,964,000689,500,000744,700,0001,030,700,000986,400,0001,154,600,0001,259,100,0001,286,400,0001,340,000,000
Net income
72m
P
-82,897,0001,105,00012,606,0007,200,00068,700,00054,100,00045,800,00080,500,00024,400,000-42,200,00071,700,000
CFO
224m
+41.58%
58,303,00059,932,00064,670,00070,000,000100,600,000173,600,000143,700,000195,200,000140,900,000158,000,000223,700,000
Dividend
Oct 07, 20250.24 EUR/sh
Earnings
Apr 24, 2025

Profile

Terveystalo Oyj provides occupational healthcare services in Finland. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; and outsourcing services, staffing services, child welfare services, oral health, laboratory, imaging, wellbeing, day surgery, healthcare outsourcing, healthcare staffing, and primary and specialty care services. It also provides a suite of digital healthcare services; and clinical research services. The company serves private individuals, companies and communities, insurance companies, and public sector customers. It operates 360 clinics, which include 18 hospital units and 38 dental clinics; and 73 Rela hierojat massage therapy units. The company was founded in 2001 and is based in Helsinki, Finland.
URL
https://www.terveystalo.com/
IPO date
Oct 11, 2017
Employees
10,094
Domiciled in
FI
Incorporated in
FI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,340,000
4.17%
1,286,400
2.17%
1,259,100
9.05%
Cost of revenue
560,900
1,004,100
542,000
Unusual Expense (Income)
NOPBT
779,100
282,300
717,100
NOPBT Margin
58.14%
21.94%
56.95%
Operating Taxes
18,000
3,300
6,500
Tax Rate
2.31%
1.17%
0.91%
NOPAT
761,100
279,000
710,600
Net income
71,700
-269.91%
(42,200)
-272.95%
24,400
-69.69%
Dividends
(38,000)
(35,400)
(35,400)
Dividend yield
2.85%
3.59%
4.46%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
77,000
68,800
90,700
Long-term debt
684,800
789,900
704,100
Deferred revenue
8,800
10,300
Other long-term liabilities
18,800
7,800
24,400
Net debt
696,600
821,000
753,000
Cash flow
Cash from operating activities
223,700
158,000
140,900
CAPEX
(27,300)
(24,600)
(59,200)
Cash from investing activities
(47,400)
(44,200)
(93,900)
Cash from financing activities
(148,800)
(116,200)
(44,600)
FCF
776,600
247,300
674,700
Balance
Cash
65,200
37,700
40,200
Long term investments
1,600
Excess cash
Stockholders' equity
78,000
531,100
607,800
Invested Capital
1,137,000
1,167,800
1,209,700
ROIC
66.04%
23.47%
59.92%
ROCE
67.41%
23.76%
57.87%
EV
Common stock shares outstanding
126,597
127,037
127,037
Price
10.52
35.39%
7.77
24.32%
6.25
-47.21%
Market cap
1,331,800
34.92%
987,077
24.32%
793,981
-47.49%
EV
2,028,400
1,808,077
1,546,981
EBITDA
885,500
389,200
852,000
EV/EBITDA
2.29
4.65
1.82
Interest
25,700
23,500
9,800
Interest/NOPBT
3.30%
8.32%
1.37%